Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ChangAn Outlines 2030 Vision at "Vast Ocean Plan: United Towards the Peak"-Themed Overseas Partner Conference in Chongqing
-
When a British Influencer Meets the Canton Fair
-
Este Medical Group Leeds Launches Advanced Solutions for Skin Discolouration and Pigmentation Problems
-
40 could be the new 55 if you have poor 'immune resilience,' new UT Health San Antonio-led study shows
-
Shanghai Climate Week 2025:LONGi Jiaxing Production Base becomes the world's first "Lighthouse + Zero-Carbon" factory in the global photovoltaic industry
-
ROSEN, LEADING TRIAL COUNSEL, Encourages Firsthand Technology Value Fund, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SVVC
-
Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market
-
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages enCore Energy Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EU
-
ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Ibotta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBTA
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Solaris Energy Infrastructure, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SEI
-
Sandy Vans Acquires Solid Wood Worx to Expand Product Offering in the Adventure Vehicle Market
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
-
TFII DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages TFI International Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TFI
-
Global Times: 'First strengthen yourself, then compete': firms in China's Yiwu focus on boosting competitiveness amid US tariffs
-
Yutong Bus Launches EnRoute+ Service Innovation and Tech-Driven Solutions to Redefine Commercial Vehicle Value Standards
-
Grand Opening of Bethlehem Paris Baguette Café on April 28 as the Brand Continues to Dominate the Bakery Café Space
-
Grand Opening Celebration of Leander Paris Baguette Café on May 9 as the Brand Continues to Dominate the Bakery Café Space
-
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
-
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
-
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Bitfarms Ltd. Investors to Inquire About Securities Class Action Investigation - BITF
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBAI
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BKKT
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages XP Inc. Investors to Inquire About Securities Class Action Investigation - XP
-
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Inva
-
XRP News: XploraDEX $XPL Presale Nears Completion as Final Countdown 48 Hours Begins
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TBBK
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages SoundHound AI, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SOUN, SOUNW
-
Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Perpetua Resources Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PPTA
-
Este Medical Group Introduces Innovative Exosome Hair Loss Therapy to Birmingham
-
World-Famous Master Craftsman Completes First-Ever Auto Show Build in Front of Thousands
-
RKLB DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rocket Lab USA, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 28 Deadline in Securit
-
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeti
-
NewLink Media Author Spotlight: Fred Snufflenose and the Baby Ducks by Richard Miller
-
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
-
Studies Uncover Hidden Urologic Risks—How Water, Chemicals and Everyday Exposures Impact Urinary Health
-
ACA Enrollees Face Growing Coverage Crisis: Black Book Survey Signals Rising Fears Amid Economic Instability and Proposed Healthcare Rollbacks
-
Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer
-
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
-
FOMO Builds As Bitcoin Briefly Shoots Above $94K; Investors Shift To Earn BTC Through Zaminer Cloud Mining Site
-
FOMO Builds As Bitcoin Briefly Shoots Above $94K; Investors Shift To Earn BTC Through Zaminer Cloud Mining Site
-
RAINN Statement on the Passing of Virginia Giuffre
-
Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
-
Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer
-
QUBT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Quantum Computing Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 28 Deadline in Securities Clas

